Cardiology trials demand precision, speed, and deep clinical understanding. From first-in-human device studies to large outcome trials, every endpoint matters - and every delay carries clinical consequences.
aCROss Medical brings physician-led expertise to cardiology programs across pharmaceutical, device, and combination therapies - supported by established relationships with leading cardiac centers across our four countries.
Medical monitors and principal investigators with hands-on cardiology experience.
Long-standing relationships with leading cardiology hospitals and cath labs across four countries.
Expertise with MACE, ECG adjudication, imaging endpoints, and long-term follow-up.
Large patient populations with high prevalence of cardiovascular disease and treatment-naive cohorts.
Dedicated safety monitoring, SUSAR management, and clinical event committee coordination.
Evaluating Georgia for our clinical study was a strategic exercise that exceeded our expectations, thanks to the team at aCROss Medical. Yoram and Alio went far beyond standard CRO services, thoughtfully aligning clinical strategy with our long-term regulatory goals in Europe and the US. They delivered a qualitatively high-value roadmap that prioritized ethical soundness and timely execution. A standout moment was their rapid mobilization of the local clinical network; we were able to conduct several deep-dive sessions with Tbilisi-based specialists on very short notice.
Ultimately, aCROss helped us reach a critical decision: for this specific study, the unique transplant policy features we required were only available in the US. The fact that aCROss helped us arrive at this 'right' conclusion - rather than simply pushing their local services - speaks volumes about their integrity. For any medical device company weighing international clinical options, aCROss is an indispensable partner.
Whether you're developing a next-generation stent, a novel anticoagulant, or an implantable cardiac device - we'd love to hear about your program.
Discuss Your Study